EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
68 hedge funds and large institutions have $161M invested in Evelo Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less capital invested
Capital invested by funds: $290M → $161M (-$129M)
78% less call options, than puts
Call options by funds: $49K | Put options by funds: $221K
Holders
68
Holding in Top 10
2
Calls
$49K
Puts
$221K
Top Buyers
| 1 | +$1.11M | |
| 2 | +$687K | |
| 3 | +$450K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$375K |
| 5 |
Two Sigma Investments
New York
|
+$307K |
Top Sellers
| 1 | -$6.07M | |
| 2 | -$243K | |
| 3 | -$221K | |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
-$157K |
| 5 |
BlackRock
New York
|
-$146K |